Cellectar Biosciences, Inc.

CLRB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$23,289$9,565$19,866$35,704
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$962$888$663$867
Total Curr. Assets$24,250$10,453$20,530$36,571
Property Plant & Equip (Net)$1,194$1,593$979$549
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$30$30$81$81
Total NC Assets$1,224$1,622$1,060$630
Other Assets$0$0$0$0
Total Assets$25,474$12,076$21,590$37,202
Liabilities
Payables$4,105$5,620$2,558$1,415
Short-Term Debt$84$59$51$135
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,198$19,680$8,893$2,440
Total Curr. Liab.$9,388$25,359$11,502$3,990
LT Debt$410$494$553$166
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,382$0$0$0
Total NC Liab.$1,792$494$553$166
Other Liabilities$0$0$0$0
Cap. Leases$494$553$604$302
Total Liabilities$11,179$25,853$12,055$4,157
Equity
Pref Stock$521$6,060$1,382$1,382
Common Stock$0$0$0$1
Retained Earnings-$247,342-$202,761-$159,990-$150,898
AOCI$0$0$0$0
Other Equity$261,116$182,924$168,144$182,560
Total Equity$14,295-$13,777$9,535$33,045
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$25,474$12,076$21,590$37,202
Net Debt-$22,795-$9,012-$19,263-$35,402
Cellectar Biosciences, Inc. (CLRB) Financial Statements & Key Stats | AlphaPilot